Painkiller vs. bacteria: lab study tests Levobupivacaine's Germ-Killing power
NCT ID NCT07285759
First seen Jan 05, 2026 · Last updated May 16, 2026 · Updated 20 times
Summary
This study looked at whether levobupivacaine, a pain medicine used in patient-controlled pumps, can kill Staphylococcus aureus bacteria in a lab setting. Researchers tested two common doses and measured how many bacteria survived. The study was done in a lab, not on people, and aimed to understand if the drug has any antibacterial effect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAPHYLOCOCCUS AUREUS BACTERIAL CONTAMINATION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.